Be warned: just reading the list of all the things Agnė Vaitkevičienė does to make a living could tire you out. As well as being CEO of Memel Biotech in her native Lithuania, she is the chief commercial officer of the Cureline Group, the US firm which partners it, and the vice president of the Lithuania Bio trade association. In her spare time, she lectures at two universities, one in the capital, Vilnius, and one in the city of Klaipėda. And, as if that were not enough, she is also a mother of three – the youngest arrived last year and was sitting to one side while I interviewed her.
“I worked out early on that I cannot just focus on one process at a time,” Vaitkevičienė said. “Even during...
